Neurocognitive enhancement or impairment? A systematic meta-analysis of prescription stimulant effects on processing speed, decision-making, planning, and cognitive perseveration.
Open Access
- 1 August 2016
- journal article
- research article
- Published by American Psychological Association (APA) in Experimental and Clinical Psychopharmacology
- Vol. 24 (4) , 269-284
Abstract
Increasing numbers of adults, particularly college students, are misusing prescription stimulants primarily for cognitive/academic enhancement, so it is critical to explore whether empirical findings support neurocognitive benefits of prescription stimulants. Previous meta-analytic studies have supported small benefits from prescription stimulants for the cognitive domains of inhibitory control and memory; however, no meta-analytic studies have examined the effects on processing speed or the potential impairment on other domains of cognition, including planning, decision-making, and cognitive perseveration. Therefore, the present study conducted a meta-analysis of the available literature examining the effects of prescription stimulants on specific measures of processing speed, planning, decision-making, and cognitive perseveration among healthy adult populations. The meta-analysis results indicated a positive influence of prescription stimulant medication on processing speed accuracy, with an overall mean effect size of g = 0.282 (95% CI [0.077, 0.488]; n = 345). Neither improvements nor impairments were revealed for planning time, planning accuracy, advantageous decision-making, or cognitive perseveration; however, findings are limited by the small number of studies examining these outcomes. Findings support that prescription stimulant medication may indeed act as a neurocognitive enhancer for accuracy measures of processing speed without impeding other areas of cognition. Considering that adults are already engaging in illegal use of prescription stimulants for academic enhancement, as well as the potential for stimulant misuse to have serious side effects, the establishment of public policies informed by interdisciplinary research surrounding this issue, whether restrictive or liberal, is of critical importance. (PsycINFO Database RecordKeywords
Funding Information
- University of Rhode Island
- National Institutes of Health (G20RR030883)
- National Institute of Mental Health (R01MH105379)
This publication has 76 references indexed in Scilit:
- Long-acting methylphenidate formulations in the treatment of attention-deficit/hyperactivity disorder: a systematic review of head-to-head studiesBMC Psychiatry, 2013
- Prescription stimulants in individuals with and without attention deficit hyperactivity disorder: misuse, cognitive impact, and adverse effectsBrain and Behavior, 2012
- The weight of nations: an estimation of adult human biomassBMC Public Health, 2012
- Deterministic learning and attempted suicide among older depressed individuals: Cognitive assessment using the Wisconsin Card Sorting TaskJournal of Psychiatric Research, 2012
- Methylphenidate produces selective enhancement of declarative memory consolidation in healthy volunteersPsychopharmacology, 2011
- Are prescription stimulants “smart pills”? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals.Psychological Bulletin, 2011
- Comparison of the Behavioral and Cardiovascular Effects of Intranasal and Orald-Amphetamine in Healthy Human SubjectsThe Journal of Clinical Pharmacology, 2011
- Understanding the Effect Size of Lisdexamfetamine Dimesylate for Treating ADHD in Children and AdultsJournal of Attention Disorders, 2010
- Increasing Speed of Processing With Action Video GamesCurrent Directions in Psychological Science, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003